This randomised study aimed to compare the biochemical tolerance of three parenteral regimens administered during the first 48 hours of life. Twenty nine infants were randomised to either: (a) glucose 10%; (b) glucose 100/o/amino acids; (c) glucose 100/olamino acids/lipid.
Intravenous nutrition continues to have an important role in the management of sick preterm infants. For many years infants requiring total parenteral nutrition (TPN) have traditionally been given initially a glucose solution and subsequently amino acids and lipid emulsion gradually introduced towards the end of the first week of life.' This cautious approach originates from the earliest developments in neonatal TPN regimens when there was concern that immaturity of intermediate metabolism would limit tolerance of parenteral fluids. 23 A consequence of this approach is that the nutritional needs of the infant are not being met during the first days of life, when the infant is frequently most sick and in need of optimal nutrition. 4 With increasing recognition that early diet may not only impact on immediate survival5 but also influence long term wellbeing,6 the need for a significant interruption in the nutritional supply of the newbom infant at such a vital time merits further consideration.
Over the past 20 years, *there have been considerable improvements in the quality of nutritional fluids. Metabolic complications associated with the earlier amino acid solutions7 8 are now less common. However, there is still concern that some solutions are associated with potentially dangerous concentrations of plasma phenylalanine and tyrosine.9 Early concerns that lipid solutions might increase the risk of kernicterus'0 have been followed by reports that fat emulsions may seriously impair lung function."I 12 However, more recently, others have reported that polyunsaturated fats present in fat emulsion may have a vital role in protecting immature lungs from oxygen toxicity.'3 Furthermore, the important part played by long chain polyunsaturated fatty acids (LCPs) in the development of visual and cortical function is increasingly being recognised.'4 15 Essential fatty acid stores in preterm infants are low at birth, and in the absence of lipid intake fatty acid deficiency may occur within five days. '6 From these data it can be concluded that there are potential health gains to be achieved from the earlier administration of parenteral nutrients, provided that the parenteral fluids are tolerated by the infant. Separate studies suggest that preterm infants can tolerate intravenous amino acids'7 and fat emulsion'8 immediately after birth. We undertook a randomised study to compare directly the biochemical tolerance of three parenteral regimens administered during the first 48 hours of life.
Methods
Infants weighing less than 2000 g at birth, who for clinical reasons could not receive enteral feeds immediately after birth, were recruited to the study after informed parental consent had been obtained. They were randomly allocated The Unit protocol for neonatal hypoglycaemia determined that if a plasma glucose of less than 2-6 mmol/l was recorded intravenous glucose load should be increased to 10 mg/kg/minute, and if this did not maintain an adequate plasma glucose, glucagon was to be administered intravenously. Infants fed more than 1 ml/hour of expressed breast milk or formula were withdrawn from the study.
Blood samples for plasma amino acid profiles, cholesterol, and triglyceride concentrations were taken on arrival in the neonatal unit and again between 36 and 48 hours of life. The results from the initial samples taken within an hour of delivery, provided a baseline 'normal range' against which the 48 hour concentrations were compared. Amino acid analysis was carried out by anion exchange chromatography with ninhidrin detection on a Chromakon 500 Amino Acid Analyser (Kontron Instruments, Watford, UK). Cholesterol and triglyceride assays were performed using standard enzymatic methods on a Cobas Fara analyser (Roche Diagnostic Systems, Welwyn Garden City, UK). Arterial or capillary blood gas analysis and blood glucose estimates were performed routinely during the first 48 hours of life.
Results
Out of 44 infants entered into the study 15 rapidly progressed to milk feeding and were withdrawn, leaving 11 in group a, 10 in group Table 3 Actualfluid, nutrient, and energy intake during study regimens (20) ,umolll) and the need for phototherapy (nine v eight v five infants) were similar for each of the groups.
Discussion
This study shows that moderate intakes of intravenous amino acids and fat emulsion can be tolerated immediately after birth by low birthweight infants.
There was a rapid decline in plasma amino acid concentrations during the first days of life in infants not receiving amino acids as part of their parenteral nutrition regimen. In those infants who did receive amino acids there were negative differences for some of the amino acids but the overall profile was much closer to baseline values. The amino acid profile of the infants receiving lipid in addition to amino acids (c) did not significantly differ from the infants receiving only glucose with amino acid (b).
Measurements of plasma amino acids rapidly reflect short term dietary manipulations, including protein restriction. ' previous study comparing glucose alone with glucose and amino acids, at the end of the first week of life the plasma amino acid pattern in the glucose alone group resembled that seen in infants with protein malnutrition states, the essential amino acid concentrations being substantially lowered and non-essential amino acids being maintained closer to normal levels by endogenous protein breakdown.20 In our study the amino acid profile of group (a) showed low values for both essential and nonessential amino acids. Our infants were studied during the first 48 hours of life and therefore, in addition to the lack of supply of amino acids, the infants were also subject to the metabolic milieu which prevails immediately after birth. Leucine (L) 81-6 ( 4 7) 49 (5 3) 85-2 (10-1) 67-3 (7 6) Tyrosine (Ty) 81-2 ( 5 5) 90 (21) 248 (48) 354 (97 8) Phenylalanine (Ph) 65-9 (3 5) 100 (47) 131-7 (18-6) 104 Tryptophan (Tr) 64-9 (4 5) 28-6 (7 5) 54-4 ( 5 7) 62-1 (3-7) Ornithine (0) 110-4 (5 9) 41-4 (9 3) 54-5 (7) 65-4 Histidine (H) 93-6 (5 5) 51-8 (6 6) 97 5 (11) 84-8 Lysine ( 51-1 ( 8 7) 19 (5 5) 42 (10-3) 34-7 (11-7)
Values: mean (SE) ,umo1lA.
Plasma amino acid profile: glucose regimen low plasma amino acid concentration and negative nitrogen balance is hazardous to the infant either at the time or in the longer term the amino acid solution used in this study is associated with substantially increased values of tyrosine and phenylalanine.9 It has been suggested that high concentrations of phenylalanine occur more commonly when the ratio of total energy intake to protein energy intake is low.26 Although the same study was unable to demonstrate an association between increased plasma phenylalanine and impaired mental development, motor development, or social maturity at 18 months of age, we agree with the view that a reduction in intake of 
and the plasma taurine concentrations were very low in each of the three groups. As the ability of preterm infants to synthesise taurine is limited, taurine has been added to more recently marketed amino acid solutions.9
In low birthweight infants the regulation of glucose homeostasis is extremely delicate and hypoglycaemia and hyperglycaemia are common.27 In addition to glucose intake, other determinants of plasma glucose instability at this time include variability in energy expenditure; immaturity of glucoregulatory mechanisms28; endogenous glucose production, which, in contrast to adults, is not suppressed in the newborn period by exogenous glucose infusion29; and increased plasma free fatty acid concentrations, which can occur during fat infusion, and which may inhibit glucose utilisation. 30 In our study hypoglycaemia occurred most frequently in the (b) group and least commonly in the (c) group. This may be related to the energy intake of the glucose/ amino acid group not meeting the energy cost of increased protein synthesis following the administration of amino acids.31 The measures which were taken to treat hypoglycaemia resulted in there being no significant difference in the centiles for plasma glucose for each of the three feeding regimens.
The plasma triglyceride and cholesterol concentrations were similar in each of the three groups, indicating that the dose of lipid prescribed (1 g/kg/day) was within the infant's capacity to hydrolyse triglyceride. Free fatty acid concentrations were not measured in this study and therefore whether the fatty acids were effectively metabolised was not determined. Brans 8.18 There is evidence that essential fatty acid deficiency is more likely to occur in infants fed glucose and amino acid solutions compared with infants receiving glucose alone and therefore if amino acids are being administered the provision of at least maintenance fat requirement is recommended. 20 The activity of lipoprotein lipase, the enzyme responsible for the hydrolysis of intravenous triglyceride, has been shown to be independent of intake,33 and therefore it has been suggested that the practice of slowly increasing fat emulsion during the introduction of parenteral nutrition is unnecessary. In support of this, there is evidence that newborn infants adapt very rapidly to intravenous fat administration, fat oxidation becoming the main source of energy within hours of starting fat infusion.34 That study also showed that the ability of the newborn to metabolise exogenous fat is not influenced by caloric intake, and therefore a period of high caloric intake of glucose and amino acids is not an essential prerequisite to the administration of a full dose of fat emulsion. In our study the infants who received lg/kg/day of fat emulsion not only received an additional source of energy which placed them in positive energy balance, according to recent energy expenditure data on sick preterm infants,35 but also fulfilled their essential fatty acid requirements. 36 Premature birth deprives infants of the continuous infusion of glucose, fatty acids, and amino acids which they receive in utero and which contributes to the massive accretion of nutrients during the last trimester of pregnancy.37 Data from this study indicate that restriction of the nutritional intake of preterm infants immediately after birth may cause clinically important metabolic disturbance. Whether this nutritional insult, occurring at such a critical period of infant development, has longer term consequences is not known.6 In a study of the brain growth of beagle puppies it was shown that after 10 days of either normal feeding, TPN, or 10% glucose, normal brain mass and cell number were demonstrated in the TPN group, but not in those puppies receiving glucose alone. 38 This study shows that infants can tolerate intravenous macronutrients immediately after birth and neonatal parenteral nutrition regimens should be further refined to meet the specific needs of sick preterm infants, and ensure that the transfer from fetal to postnatal life is achieved with the minimum of interruption to nutrient provision.
